These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3153789)

  • 21. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
    Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
    Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithyrotropin antibodies in the sera of Graves' disease patients.
    Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
    J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSH receptor antibody in autoimmune thyroiditis and its clinical significance.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):748-54. PubMed ID: 2878965
    [No Abstract]   [Full Text] [Related]  

  • 25. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin (TSH) receptor modulation by specific TSH receptor antibodies in Graves' disease.
    de Bruin TW; Bussemaker JK; Heidema J; Hermans J; van der Heide D
    J Clin Endocrinol Metab; 1988 Oct; 67(4):676-81. PubMed ID: 2901428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin G that interferes with thyroid-stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor.
    Ueda Y; Sugawa H; Akamizu T; Okuda J; Kiho Y; Mori T
    Thyroid; 1993; 3(2):111-7. PubMed ID: 8103692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
    Paunković N; Paunković D
    Med Pregl; 1995; 48(1-2):10-4. PubMed ID: 8657049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Miyai K
    J Endocrinol Invest; 1989 Jan; 12(1):47-53. PubMed ID: 2568374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum and significance of autoantibodies reacting with the thyrotropin receptor.
    Zakarija M; McKenzie JM
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):343-63. PubMed ID: 3319587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy.
    De Bruin TW; Patwardhan NA; Brown RS; Braverman LE
    Clin Exp Immunol; 1988 Jun; 72(3):481-5. PubMed ID: 3168323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSH-receptor antibodies in hypothyroid Graves' disease.
    Konishi J; Kasagi K; Hidaka A; Takeuchi R; Iida Y; Nakamura H
    Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-thyrotropin-receptor antibodies in Basedow's disease. Correlations with in vitro and in vivo parameters].
    Heshmati HM; Izembart M; Chevalier A; Vallée G
    Presse Med; 1986 Dec; 15(45):2253-4. PubMed ID: 2949260
    [No Abstract]   [Full Text] [Related]  

  • 38. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
    Carayanniotis G; Huang GC; Nicholson LB; Scott T; Allain P; McGregor AM; Banga JP
    Clin Exp Immunol; 1995 Feb; 99(2):294-302. PubMed ID: 7851025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.